Successful management of a leiomyomatosis peritonealis disseminata with an aromatase inhibitor

Obstetrics and Gynecology

Volumn 112, Issue 2 PART 2, 2008, Pages 491-493

  Takeda, Takashi ^a,b   Masuhara, Kanji ^a,b   Kamiura, Shouji ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; NITRILE; TRIAZOLE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; LEIOMYOMATOSIS; PATHOLOGY; PERITONEAL CAVITY; POSTMENOPAUSE;

AGED; AROMATASE INHIBITORS; FEMALE; HUMANS; LEIOMYOMATOSIS; NITRILES; PERITONEAL CAVITY; POSTMENOPAUSE; TRIAZOLES;

EID: 51149116528     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318180219b     Document Type: Article

References (8)

1. Tavassoli FA, Norris HJ. Peritoneal leiomyomatosis (leiomyomatosis peritonealis disseminata): a clinicopathologic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol 1982;1:59-74. (Pubitemid 13145740)
2. Herrero J, Kamali P, Kirschbaum M. Leiomyomatosis peritonealis disseminata associated with endometriosis: a case report and literature review. Eur J Obstet Gynecol Reprod Biol 1998;76:189-91. (Pubitemid 28031911)
3. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
4. Strinić T, Kuzmić-Prusac I, Eterović D, Jakić J, Sćukanec M. Leiomyomatosis peritonealis disseminata in a postmenopausal woman. Arch Gynecol Obstet 2000;264:97-8.
5. Nigojevic S, Kapural L, Scukanec-Spoljar M, Andelinovic S, Jankovic S, Jukic DM, et al. Leiomyomatosis peritonealis disseminata in a postmenopausal woman. Acta Obstet Gynecol Scand 1997;76:893-4. (Pubitemid 27429891)
6. Sumitani H, Shozu M, Segawa T, Murakami K, Yang HJ, Shimada K, et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology 2000;141:3852-61.
7. Palomba S, Orio F Jr, Russo T, Falbo A, Tolino A, Lombardi G, et al. Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women. Fertil Steril 2005;84:154-61. (Pubitemid 40991475)
8. Ghosh K, Dorigo O, Bristow R, Berek J. A radical debulking of leiomyomatosis peritonealis disseminata from a colonic obstruction: a case report and review of the literature. J Am Coll Surg 2000;191:212-5. (Pubitemid 30622469)